South Africa approves AstraZeneca vaccine for emergency use
CAPE TOWN, Jan 27 (Reuters) - South Africa has approved AstraZeneca's COVID-19 vaccine for emergency use and is reviewing applications by rival manufacturers, Johnson & Johnson and Pfizer, the medicines regulator said on Wednesday.
"In terms of the AstraZeneca vaccine … this has been granted emergency use (approval) and there will be a press conference with the minister of health on this (later)," said Helen Rees, chairwoman of the South African Health Products board, during a media briefing. (Reporting by Wendell Roelf; editing by Mfuneko Toyana)
© Copyright Reuters Ltd. All rights reserved. The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Reuters Ltd.